DPP4 and acute pancreatitis: The other two1,3 found an increased risk of acute pancreatitis in patients treated with DPP-4 inhibitors; however, they included only three large cardiovascular randomised trials, namely, EXAMINE, SAVOR-TIMI 53 and TECOS18–20.